Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,777 JPY | -1.00% | -3.90% | -2.37% |
Apr. 04 | Rohto Pharmaceutical Eyes MGO on Singapore's Eu Yan Sang International for 88 Billion Yen | MT |
Apr. 04 | Rohto Pharmaceutical, Mitsui & Co. to Acquire Singapore-Based Eu Yan Sang -- Update | DJ |
Business Summary
Number of employees: 7,176
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Skin Care
65.6
%
| 124,055 | 62.1 % | 156,657 | 65.6 % | +26.28% |
Eye Care
20.2
%
| 43,102 | 21.6 % | 48,180 | 20.2 % | +11.78% |
Internal Medicine
11.1
%
| 25,604 | 12.8 % | 26,588 | 11.1 % | +3.84% |
Other
3.0
%
| 6,884 | 3.4 % | 7,237 | 3.0 % | +5.13% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
57.3
%
| 121,417 | 60.8 % | 136,668 | 57.3 % | +12.56% |
Asia
29.7
%
| 55,988 | 28.0 % | 70,773 | 29.7 % | +26.41% |
America
7.0
%
| 10,037 | 5.0 % | 16,655 | 7.0 % | +65.94% |
Europe
5.1
%
| 10,297 | 5.2 % | 12,231 | 5.1 % | +18.78% |
Others
1.0
%
| 1,906 | 1.0 % | 2,337 | 1.0 % | +22.61% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Masashi Sugimoto
PSD | President | 62 | 18-12-31 |
Kunio Yamada
CHM | Chairman | 68 | 80-03-31 |
Masamitsu Inoue
DFI | Director of Finance/CFO | - | - |
Atsushi Hiyama
BRD | Director/Board Member | 58 | 20-03-31 |
Chiharu Takakura
BRD | Director/Board Member | 64 | 20-03-31 |
Masaya Saito
BRD | Director/Board Member | 60 | 86-03-31 |
Director/Board Member | 68 | 06-12-31 | |
Corporate Officer/Principal | 65 | 82-03-31 | |
Hidetoshi Segi
PRN | Corporate Officer/Principal | 61 | 97-05-31 |
Hideto Kamimura
AUD | Comptroller/Controller/Auditor | 65 | 82-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Kunio Yamada
CHM | Chairman | 68 | 80-03-31 |
Yasuhiro Yamada
PRN | Corporate Officer/Principal | 85 | 62-02-28 |
Shingo Torii
BRD | Director/Board Member | 71 | 15-05-31 |
Masaya Saito
BRD | Director/Board Member | 60 | 86-03-31 |
Hidetoshi Segi
PRN | Corporate Officer/Principal | 61 | 97-05-31 |
Akie Iriyama
BRD | Director/Board Member | 51 | 19-05-31 |
Corporate Officer/Principal | 65 | 82-03-31 | |
Haruka Mera
BRD | Director/Board Member | 36 | 20-06-25 |
Masashi Sugimoto
PSD | President | 62 | 18-12-31 |
Eriko Hayashi
BRD | Director/Board Member | 47 | 22-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 236,178,310 | 199,736,821 ( 84.57 %) | 8,039,532 ( 3.404 %) | 84.57 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
8,039,400 | 3.40% | 157,503,101 $ | |
ASICS CORPORATION 0.21% | 408,000 | 0.21% | 17,526,644 $ |
1,380,000 | 0.01% | 13,851,295 $ | |
1,759,000 | 12.50% | 11,311,971 $ | |
MATSUKIYOCOCOKARA & CO. 0.16% | 665,700 | 0.16% | 9,505,470 $ |
YAKULT HONSHA CO.,LTD. 0.10% | 346,600 | 0.10% | 6,796,985 $ |
355,000 | 8.55% | 5,378,069 $ | |
71,100 | 0.01% | 4,057,307 $ | |
MEIJI HOLDINGS CO LTD 0.06% | 180,400 | 0.06% | 4,040,987 $ |
EUGLENA CO., LTD. 0.78% | 1,069,500 | 0.78% | 3,534,077 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.34% | 4.21B | |
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |
- Stock Market
- Equities
- 4527 Stock
- Company Rohto Pharmaceutical Co.,Ltd.